How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan
Current Oncology · 2025
DOI: 10.3390/curroncol32080453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Takeshi Morii und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka-shi 181-8611, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Bone Neoplasms, Muscle Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
While changes in clinical practice during the COVID-19 pandemic in Japan have been widely studied, data specific to bone and soft tissue tumor care remain limited.
Methods
A nationwide web-based survey was conducted among hospitals specializing in musculoskeletal tumors. It assessed the occurrence of COVID-19-related events (patient infections, outbreak clusters, and staff infections), delays in referral and diagnosis, postponement or cancellation of specific treatments, and changes in institutional management strategies.
Results
Seventy-eight hospitals (91.7% of all specialized centers) responded. Patient infections, outbreak clusters, and staff infections were reported by 28.2%, 48.7%, and 53.8% of hospitals, respectively. While radiological exams and biopsies were largely maintained, patient referrals decreased significantly. Surgical treatment was more affected than chemotherapy or radiotherapy. Strategy changes included surgery delays or cancellations (48.7%) and prolonged follow-up intervals (20.5%). Among COVID-19-related factors, only direct patient infections were significantly associated with institutional changes in treatment policy.
Conclusions
The pandemic substantially disrupted outpatient services and surgical care in musculoskeletal oncology. Patient infection was the main driver of treatment strategy modifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka-shi 181-8611, Tokyo, Japan.
- Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku 104-0045, Tokyo, Japan.
- Department of Orthopedic Surgery, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago 683-8504, Tottori, Japan.
- Department of Orthopaedic Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Nagano, Japan.
- Department of Orthopaedic Surgery, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu 520-2192, Shiga, Japan.
- Department of Orthopedics and Rehabilitation Medicine, Unit of Surgery, Division of Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaizuki, Matsuoka 910-1193, Fukui, Japan.
ORCID-Profile: Shintaro Iwata, Masanori Okamoto
Zitieren
APA
Morii, T., Iwata, S., Yamaga, K., Okamoto, M., Ando, K., Tanaka, T., & Nishida, J. (2025). How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan. Current Oncology. https://doi.org/10.3390/curroncol32080453
Vancouver
Morii T, Iwata S, Yamaga K, Okamoto M, Ando K, Tanaka T, et al. How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan. Current Oncology. 2025. doi:10.3390/curroncol32080453
BibTeX
@article{Morii2025,
author = {Morii, Takeshi and Iwata, Shintaro and Yamaga, Kensaku and Okamoto, Masanori and Ando, Kosei and Tanaka, Takaaki and Nishida, Jun},
title = {How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32080453}
}
EUVIMED